Riverbridge Partners LLC Sells 17,781 Shares of Danaher Corporation $DHR

Riverbridge Partners LLC reduced its holdings in Danaher Corporation (NYSE:DHR) by 7.4% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 222,825 shares of the conglomerate’s stock after selling 17,781 shares during the quarter. Riverbridge Partners LLC’s holdings in Danaher were worth $42,248,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Elevated Capital Advisors LLC purchased a new stake in Danaher in the fourth quarter valued at approximately $26,000. Hilton Head Capital Partners LLC bought a new stake in shares of Danaher during the 4th quarter worth $27,000. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 53 shares during the last quarter. JPL Wealth Management LLC purchased a new position in Danaher in the third quarter worth $25,000. Finally, WFA of San Diego LLC bought a new position in Danaher in the second quarter valued at $26,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

DHR opened at $179.43 on Wednesday. The stock’s 50 day simple moving average is $179.11 and its 200 day simple moving average is $202.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The firm has a market cap of $127.00 billion, a price-to-earnings ratio of 34.71, a PEG ratio of 2.27 and a beta of 0.81.

Danaher (NYSE:DHR) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter last year, the business earned $1.88 earnings per share. The business’s revenue was up 3.7% on a year-over-year basis. As a group, analysts predict that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s payout ratio is presently 30.95%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on DHR shares. Evercore raised their price target on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. JPMorgan Chase & Co. cut their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Wells Fargo & Company dropped their target price on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 22nd. Finally, Robert W. Baird cut their target price on Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.